NMP22 BladderChek Test diagnostic data

In a U.S. study in 1,331 patients at risk for bladder cancer, the NMP22 BladderChek test with cytoscopy detected 94% of the bladder cancers compared to 89% seen by cytoscopy alone (p=0.26). Of the 79 ...